Cellebrite DI Ltd. (CLBT) Stock Forecast
Data as of May 2, 2026Technology · Current price $13.29 (+2.35%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 12, 2026 | Eric Martinuzzi | Lake Street | $21.00 | +58.0% |
| Oct 23, 2024 | Tomer Zilberman | Bank of America Securities | $20.00 | +50.5% |
| Sep 25, 2024 | Jeff Van Rhee | Craig-Hallum | $23.00 | +73.1% |
| Aug 16, 2024 | Eric Martinuzzi | Loop Capital Markets | $17.00 | +27.9% |
| Aug 16, 2024 | Tomer Zilberman | Bank of America Securities | $17.00 | +27.9% |
| Apr 1, 2024 | Jeff Van Rhee | Craig-Hallum | $16.00 | +20.4% |
Top Analysts Covering CLBT
CLBT vs Sector & Market
| Metric | CLBT | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.34 | 2.41 |
| Analyst Count | 5 | 13 | 18 |
| Target Upside | +55.5% | +4072.6% | +14.9% |
| P/E Ratio | 42.39 | 27.88 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $567M | $568M | $569M | 5 |
| 2027-03-31 | $151M | $152M | $154M | 2 |
| 2027-06-30 | $157M | $159M | $161M | 2 |
| 2027-09-30 | $172M | $174M | $176M | 2 |
| 2027-12-31 | $179M | $181M | $183M | 2 |
| 2028-03-31 | $173M | $175M | $177M | 1 |
| 2028-06-30 | $176M | $178M | $180M | 1 |
| 2028-09-30 | $189M | $191M | $194M | 1 |
| 2028-12-31 | $198M | $201M | $203M | 1 |
| 2029-12-31 | $855M | $863M | $877M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.36 | $0.37 | $0.38 | 4 |
| 2027-03-31 | $0.07 | $0.07 | $0.07 | 2 |
| 2027-06-30 | $0.08 | $0.08 | $0.08 | 1 |
| 2027-09-30 | $0.11 | $0.11 | $0.11 | 1 |
| 2027-12-31 | $0.12 | $0.12 | $0.12 | 2 |
| 2028-03-31 | $0.08 | $0.08 | $0.08 | 3 |
| 2028-06-30 | $0.10 | $0.10 | $0.10 | 2 |
| 2028-09-30 | $0.14 | $0.14 | $0.14 | 2 |
| 2028-12-31 | $0.14 | $0.15 | $0.15 | 3 |
| 2029-12-31 | $0.89 | $0.90 | $0.92 | 1 |
Frequently Asked Questions
What is the analyst consensus for CLBT?
The consensus among 5 analysts covering Cellebrite DI Ltd. (CLBT) is Buy with an average price target of $20.67.
What is the highest price target for CLBT?
The highest price target for CLBT is $23.00, set by Jeff Van Rhee at Craig-Hallum on 2024-09-25.
What is the lowest price target for CLBT?
The lowest price target for CLBT is $16.00, set by Jeff Van Rhee at Craig-Hallum on 2024-04-01.
How many analysts cover CLBT?
5 analysts have issued ratings for Cellebrite DI Ltd. in the past 12 months.
Is CLBT a buy or sell right now?
Based on 5 analyst ratings, CLBT has a consensus rating of Buy (2.00/5) with a +55.5% upside to the consensus target of $20.67.
What are the earnings estimates for CLBT?
Analysts estimate CLBT will report EPS of $0.37 for the period ending 2026-12-31, with revenue estimated at $568M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.